The Team

---

Asheleigh is the visionary behind Surgical Magic's breakthrough stroke prediction technology. With a Master's degree in Biomedical Engineering from the University of Florida, she invented and holds the patent for technology used by our company. Under her leadership, Surgical Magic has achieved critical FDA designations, secured intellectual property protection, and established key clinical partnerships. Asheleigh drives our mission to transform operating rooms from reactive to predictive, ensuring surgeons have the tools they need to save lives.

Christian Garcia, who holds a Bachelor's degree in Biomedical Engineering from the University of Florida, leads the development and optimization of Surgical Magic's breakthrough predictive algorithms. With expertise in real-time data processing, Christian transforms complex surgical monitoring data into precise, actionable predictions. His work ensures our algorithms perform accurately in the demanding environment of live cardiovascular surgery, processing noisy intraoperative data to deliver reliable stroke risk assessments when seconds matter most. Christian's continuous algorithm improvements directly impact the sensitivity and specificity of our predictions, enabling surgeons to trust the insights they receive during critical procedures.

Alexis Diaz, who holds a Bachelor’s and Master’s degree in Chemical and Biomolecular Engineering from Johns Hopkins University, leads all clinical validation studies and oversees the execution of Surgical Magic’s multi-site clinical trials. With deep expertise in clinical research protocols, regulatory compliance, and data management, Alexis ensures our studies meet the highest standards for data integrity and patient safety. Her work coordinates cardiovascular surgery centers nationwide to validate our stroke prediction technology in real-world clinical settings, managing complex trial logistics while maintaining strict adherence to FDA and IRB requirements. Alexis’s meticulous approach to clinical research directly supports our path to market clearance and ensures our technology is thoroughly validated before reaching surgeons and patients.